13 hours Novo Nordisk Slumps On Tightened Outlook As Wegovy Beats, But Ozempic LagsInvestor's Business Daily
Novo Nordisk stock fell Wednesday after the drugmaker’s weight-loss drug beat forecasts, but Ozempic sales missed.
The post Novo Nordisk Slumps On Tightened Outlook As Wegovy Beats, But Ozempic Lags appeared first on Investor's Business Daily.